Kristoffersen Per Martin, Bråten Lars C H, Vetti Nils, Grøvle Lars, Hellum Christian, Storheim Kjersti, Zwart John-Anker, Assmus Jörg, Espeland Ansgar
Department of Radiology, Haukeland University Hospital, Jonas Liesvei 65, 5021, Bergen, Norway.
Department of Clinical Medicine, University of Bergen, P.O. Box 7804, 5020, Bergen, Norway.
Eur Radiol. 2021 Jun;31(6):4285-4297. doi: 10.1007/s00330-020-07542-w. Epub 2020 Nov 27.
To evaluate potential MRI-defined effect modifiers of amoxicillin treatment in patients with chronic low back pain and type 1 or 2 Modic changes (MCs) at the level of a previous lumbar disc herniation (index level).
In a prospective trial (AIM), 180 patients (25-64 years; mean age 45; 105 women) were randomised to receive amoxicillin or placebo for 3 months. Primary outcome was the Roland-Morris Disability Questionnaire (RMDQ) score (0-24 scale) at 1 year. Mean RMDQ score difference between the groups at 1 year defined the treatment effect; 4 RMDQ points defined the minimal clinically important effect. Predefined baseline MRI features of MCs at the index level(s) were investigated as potential effect modifiers. The predefined primary hypothesis was a better effect of amoxicillin when short tau inversion recovery (STIR) shows more MC-related high signal. To evaluate this hypothesis, we pre-constructed a composite variable with three categories (STIR1/2/3). STIR3 implied MC-related STIR signal increases with volume ≥ 25% and height > 50% of vertebral body and maximum intensity increase ≥ 25% and presence on both sides of the disc. As pre-planned, interaction with treatment was analysed using ANCOVA in the per protocol population (n = 155).
The STIR3 composite group (n = 41) and STIR signal volume ≥ 25% alone (n = 45) modified the treatment effect of amoxicillin. As hypothesised, STIR3 patients reported the largest effect (- 5.1 RMDQ points; 95% CI - 8.2 to - 1.9; p for interaction = 0.008).
Predefined subgroups with abundant MC-related index-level oedema on STIR modified the effect of amoxicillin. This finding needs replication and further support.
• In the primary analysis of the AIM trial, the effect of amoxicillin in patients with chronic low back pain and type 1 or 2 MCs did not reach the predefined cut-off for clinical importance. • In the present MRI subgroup analysis of AIM, predefined subgroups with abundant MC-related oedema on STIR reported an effect of amoxicillin. • This finding requires replication and further support.
评估在既往腰椎间盘突出症(索引节段)水平存在1型或2型Modic改变(MCs)的慢性下腰痛患者中,MRI所定义的阿莫西林治疗潜在效应修饰因素。
在一项前瞻性试验(AIM)中,180例患者(25 - 64岁;平均年龄45岁;105名女性)被随机分组,接受阿莫西林或安慰剂治疗3个月。主要结局是1年时的罗兰-莫里斯残疾问卷(RMDQ)评分(0 - 24分)。两组在1年时的平均RMDQ评分差异定义治疗效果;4个RMDQ评分点定义最小临床重要效果。对索引节段MCs的预定义基线MRI特征作为潜在效应修饰因素进行研究。预定义的主要假设是当短tau反转恢复(STIR)显示更多与MC相关的高信号时,阿莫西林的效果更好。为评估该假设,我们预先构建了一个有三个类别的复合变量(STIR1/2/3)。STIR3意味着与MC相关的STIR信号增加,体积≥椎体的25%且高度>椎体的50%,最大强度增加≥25%且椎间盘两侧均存在。按照预先计划,在符合方案人群(n = 155)中使用协方差分析(ANCOVA)分析与治疗的相互作用。
STIR3复合组(n = 41)和仅STIR信号体积≥25%组(n = 45)改变了阿莫西林的治疗效果。如假设的那样,STIR3患者报告的效果最大(-5.1个RMDQ评分点;95%置信区间-8.2至-1.9;相互作用p值 = 0.008)。
在STIR上具有大量与MC相关的索引节段水肿的预定义亚组改变了阿莫西林的效果。这一发现需要重复验证和进一步支持。
• 在AIM试验的主要分析中,阿莫西林在慢性下腰痛和1型或2型MCs患者中的效果未达到预定义的临床重要性临界值。• 在目前AIM的MRI亚组分析中,在STIR上具有大量与MC相关水肿的预定义亚组报告了阿莫西林的效果。• 这一发现需要重复验证和进一步支持。